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ABSTRACT The arrangement of the antimicrobial peptide alamethicin was studied by oriented circular dichroism, 31P solid-
state NMR, and differential scanning calorimetry in ether-linked phospholipid bilayers composed of 1,2-O-dihexadecyl-sn-
glycero-3-phosphocholine (DHPC). The measurements were performed as a function of alamethicin concentration relative to
the lipid concentration, and results were compared to those reported in the literature for ester-linked phospholipid bilayers. At
ambient temperature, alamethicin incorporates into the hydrophobic core of DHPC bilayers but results in more lipid disorder
than observed for ester-linked 1-palmitoyl, 2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC) lipid bilayers. This orientational
disorder appears to depend on lipid properties such as bilayer thickness. Moreover, the results suggest that alamethicin inserts
into the hydrophobic core of the bilayers (at high peptide concentration) for both ether- and ester-linked lipids but using a
different mechanism, namely toroidal for DHPC and barrel-stave for POPC.
INTRODUCTION
Alamethicin is a well-characterized member of the peptaibol
family, a class of short, antimicrobial peptides known to
cause permeabilization of bacterial membranes. Peptaibols
are generally a-helical in structure and form ion channels in
microbial cell membranes in response to changes in trans-
membrane potential (reviewed in Jen et al. (1) and Bechinger
(2,3)). Experimentally, they are found to be capable of
forming transmembrane pores in the absence of a potential
difference. This phenomenon requires certain structural and
physiochemical conditions, several of which are not yet well
deﬁned (4–6). Alamethicin, like other membrane-active pep-
tides, may assume one of two orientations when associated
with lipid bilayers. In one arrangement, the peptide is ad-
sorbed on the bilayer surface (3,4,7,8). In this case, the
peptaibol is said to be in the inactive surface (S) state, and no
active transmembrane pores can be detected by neutron dif-
fraction (9). Under certain sample conditions, however, all
the peptide molecules can adopt a transmembrane orienta-
tion, which is characteristic of the inserted (I) state (10), for
which functional ion channels have been observed (4).
The insertion of alamethicin (and other antimicrobial
peptides) into the membrane depends upon several factors,
such as peptide/lipid (P/L) molar ratio, elasticity and struc-
ture of the bilayer, and physiological factors (e.g., degree of
hydration) of the bilayer. In the case of the concentration
(P/L), alamethicin has been speciﬁcally found to have
a sigmoidal concentration dependence (6). That is, at very
low P/L molar ratios, the S state is observed. However, above
some critical threshold peptide concentration (P/L*) in-
sertion of a fraction of the molecules occurs, and some lytic
activity is detected (11,2). As the P/L ratio is increased, a
coexistence region between the S and I states is observed,
until the I state is eventually reached at very high P/L
(7,10,13). It is worth noting that cytolytic activity may also
be induced experimentally in the S state by applying
a transmembrane voltage rather than increasing the P/L ratio
(14). Much of this previous work has focused on determining
the threshold P/L* value for alamethicin in various types of
membranes under different physiological conditions to better
explain the speciﬁcity of antimicrobial peptides for selected
microbes (6,7,15,16). All these studies have been carried out
using ester-linked phospholipid bilayers.
The aim of this study is to extend this work to lipid
bilayers which have different properties (e.g., phase, bilayer
thickness), namely ether-linked lipids. More speciﬁcally, we
have chosen to investigate the concentration dependence of
alamethicin in the ether-linker lipid di-hexadecyl phospho-
choline (DHPC), which exists in an interdigitated phase at
ambient temperature in the absence of any inducer (17–19).
Such interdigitated bilayer structures have attracted consid-
erable interest because of the different bilayer structures they
can form and their possible implications for membrane
function. In addition, ether-linked phospholipids have re-
cently attracted much attention as a platelet-activating factor
(20). They have also displayed antitumor activity and have
been found to be the major lipid of archaebacterial mem-
branes (21). From an NMR point of view, these types of
lipids are also of interest as they do not possess any carbonyl
moieties, which can be advantageous when studying mem-
brane-interacting peptides, since the signal in the 180–170
ppm region of a 13C spectrum would then arise solely from
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the peptide (22,23). Finally, ether-linked lipids can be used
to form bicelles (24–26).
To characterize the state (I or S) of alamethicin in
DHPC, a combination of oriented circular dichroism (OCD),
31P solid-state NMR, and differential scanning calorimetry
(DSC) data were collected and analyzed. Each of these
methods has been used to characterize the interaction of
membrane-bound peptides with lipids in complementary
ways. OCD spectroscopy can be applied to helical peptides
bound to oriented planar phospholipid bilayers and thereby
provide a direct measure of the orientational distribution of
helices with respect to the incident light beam (7). The tech-
nique has proven particularly useful for tracking changes
in alamethicin orientation which can occur in response to
changes in peptide surface density, bilayer hydration, acyl-
chain saturation, or lipid phase (4,5,7,27). 31P solid-state
NMR can be used to probe the degree alignment of lipid
bilayers and the mobility of lipid headgroups, by using
mechanically aligned phospholipid bilayers on glass plates
(28–30). Using 31P and 15N NMR, for instance, Bechinger
et al. (28) demonstrated how the insertion of alamethicin and
the related peptaibol, zervamicin, depends on the hydropho-
bic thickness of the lipid bilayer relative to the peptide
length. Finally, DSC is a powerful thermodynamic technique
for probing the nature and stoichiometry of lipid-peptide
interactions and for providing information about the location
and aggregation state of peptides and their lipid-bound state
(31). It has been used to probe phase transitions of pure
phospholipids (32,33) and perturbations induced by lipid-
interacting peptides (34–36). For instance, DSC studies
carried out for multilamellar vesicle (MLV) samples com-
posed of phospholipids isolated from Thermoplasma acid-
ophilum and alamethicin have shown that the peptide
broadens the lipid phase transition of the main phospholipid
from T. acidophilum (37). Moreover, alamethicin was found
to interact primarily with the lipid headgroups and to readily
incorporate into the tetraether lipid structures.
Results from these three types of experiments applied
to alamethicin in DHPC allow us to propose a mode of in-
sertion of this peptaibol in an interdigitated ether-linked
phospholipid for the ﬁrst time. Comparison to the insertion
of alamethicin in ester-linked membrane bilayers, in gel (1,2-
dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC)) or
the La phase (1-palmitoyl, 2-oleoyl-sn-glycero-3-phospha-
tidylcholine (POPC)) at room temperature, is also made.
MATERIALS AND METHODS
Materials
DHPC, POPC, 1,2-diphytanoyl-sn-glycero-3-phosphatidylcholine (DPhPC),
and DPPC were purchased from Avanti Polar Lipids (Alabaster, AL).
POPC, DPhPC, and DHPC were obtained in chloroform, and DPPC was
obtained in powder form. Alamethicin was purchased from Sigma-Aldrich
Chemical (St. Louis, MO). Both peptide and lipid were used without further
puriﬁcation. Alamethicin was dissolved in a 1:1 v/v methanol/chloroform
mixture to make a 0.125 mM stock solution.
Mechanically oriented sample preparation
For circular dichroism spectra, 0.5 mmol alamethicin (4 mL of stock
solution) was mixed with the appropriate quantity of DPhPC, DHPC, or
DPPC, already fully dissolved in 1:1 methanol/chloroform, in a 25 mL round
bottom ﬂask. The contents of the ﬂask were sonicated for 10 min, and the
resulting solution was dried under a stream of N2 to produce a clear layer
which coated the bottom of the ﬂask. The sample was then vacuum
dessicated overnight at room temperature to ensure that any residual solvent
was removed. After drying, the sample was hydrated with 2 ml deionized
water to yield a peptide concentration of 0.25 mM and sonicated until all
lipid and peptide were fully dissolved. To prepare solution samples at a
1:30 P/L molar ratio, an 83 dilution was made of the appropriate hydrated
solution. The diluted solution was used to measure solution circular
dichroism in a clean quartz cuvette with 1.0 mm path length (d). To prepare
oriented samples, 90 mL of the hydrated sample was deposited onto a clean
quartz slide (the quartz slides had been thoroughly cleaned with both water
and ethanol and allowed to air dry repeatedly) which measured 3 3 1 cm
with thickness of 1 mm. Each slide was ﬁtted with a spacer of thickness;1
mm which formed a ;2 mm-wide frame around the slide. Spacers were
made of six layers of stacked paraﬁlm. The hydrated sample was deposited
on each slide in small droplets via a syringe, ensuring that the mixture
covered the entire surface area of the slide. This method resulted in the
formation of oriented multilayers (38). Slides were then incubated overnight
in a sealed dessicator at 93% relative humidity and 37C. When removed
FIGURE 1 Overlay of OCD spectra of alamethicin at (A) 20C in the pres-
ence of ether-linked DHPC as a function of peptide/lipid concentration:
P/L ¼ 1:15 (diamonds), P/L ¼ 1:30 (squares), P/L ¼ 1:40 (triangles), and
P/L ¼ 1:120 (crosses); and (B) at 50C as a function of peptide/lipid
concentration: P/L ¼ 1:15 (diamonds), P/L ¼ 1:40 (triangles), and P/L ¼
1:120 (bars).
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from the incubator, the hydrated sample was present on the slide as a clear
gel-like layer. A clean second, dry quartz slide was placed on top of the
paraﬁlm spacer on the ﬁrst slide and pressed ﬁrmly against it. For the NMR
experiments, samples were prepared using the same procedure as described
above, except that the sample was spread onto 20 glass slides (113 11 mm)
and 1–3 mg of alamethicin was used.
Unoriented sample preparation
An aliquot corresponding to 25 mg of the appropriate lipid dissolved in
chloroform was deposited into a test tube, along with the alamethicin. The
chloroform was then removed using N2 gas for 15–20 min. The test tube was
placed in a vacuum dessicator overnight to remove any residual solvents.
The lipid mixture was resuspended in 100 mL water by heating in a water
bath at 50C. Once all the phospholipids were fully dissolved, the MLV
sample was transferred to an NMR rotor. For the T1 measurements, the
samples were prepared using 50% (w/w) lipid, 50 mM TRIS buffer, pH 7.4,
to which 1 mM EDTA was added, as outlined in Tamm and Seelig (39).
OCD spectroscopy
Circular dichroism measurements were made on a Jasco (Easton, MD) J-810
Spectrometer at 20C and 50C. At the latter temperature, samples were
equilibrated for a minimum of 20–30 min before data acquisition. The
spectra were acquired over a wavelength range of 250–190 nm, using 0.5 nm
steps and a scan speed of 100 nm/min. To obtain an increased signal/noise
ratio, each recorded spectrum was the average of three scans. Measurements
were made with the incident light normal to the substrate surface (7). The
light passed through a circular chasm 1 cm in diameter before reaching the
quartz slide. The acquired spectrum did not change after lengthwise rotation
of the quartz slide by 180, indicating that neither spectral artifacts in the
quartz nor inhomogeneities in the sample were contributing signiﬁcantly to
the spectra. Any contribution of the lipids to each spectrum was corrected for
by subtracting a background spectrum, containing only lipid, from the
spectrum obtained for the peptide-containing sample.
NMR spectroscopy
31P NMR spectra were recorded on a Varian (Palo Alto, CA) 400-MHz
NMR spectrometer operating at 161.80 MHz using a static double resonance
ﬂat coil (11 3 11 mm) probe for mechanically aligned bilayer samples and
a Varian triple resonance TXI MAS probe equipped with a 4 mm diameter
rotor for the MLV samples. The 31P NMR spectra were recorded with 1H
decoupling using a 4.2 ms p/2 pulse and a 3 s recycle delay. For the 31P
NMR spectra, 1024 scans were taken and the free induction decay was
processed using 100 Hz of line broadening. The spectral width was set to
50 kHz. The spectra for the aligned samples were repeated three times
(i.e., using three different samples) for each P/L ratio to ensure that the
spectra were reproducible.
Phosphorus T1 measurements were performed using an inversion-
recovery pulse sequence p-t-p/2 with proton decoupling and with a recycle
time of 3 s (40,41) (see Supplemental Material for spectra). To ﬁrst
approximation, the inversion recovery of the whole powder pattern could be
described by a single T1 value. Consequently, the T1 values were deter-
mined at the chemical shift value of 16 ppm for the MLV samples.
Differential scanning calorimetry
MLVs of DHPC, DPPC, DPhPC, 1:15 alamethicin/DHPC, and 1:80
alamethicin/DHPC, with a ﬁnal lipid concentration of 25 mg/ml were pre-
pared by dissolving the desired lipid in chloroform. The lipid samples were
then dried under a stream of nitrogen and then further dried under vacuum
overnight to remove any residual solvent. Alamethicin was added to the
dried lipid sample at the desired P/L molar ratio. The samples were then
resuspended with a buffer containing 20 mM HEPES pH 7.0 and 100 mM
NaCl. The resuspended samples were vortexed vigorously three times while
heating the sample above the phase transition peak (44C–45C) for 5 min in
between each vortex step. The buffers and lipid samples were degassed for
5 min before loading the sample into a MC (multicell)-DSC (Calorimetry
Sciences, South Provo, UT), located at the University of British Columbia
Centre for Biological Calorimetry. The samples were heated and cooled
between a temperature range of 5C–90C at a heating (cooling) rate of
0.333C/min. The resulting data were converted to molar heat capacity and
baseline corrected by subtracting a blank buffer scan. Each experiment was
repeated at least twice to ensure reproducibility of the results.
RESULTS AND DISCUSSION
Fig. 1, A and B, shows the normalized (at the isodichroic
point) OCD spectra of samples of fully hydrated alamethicin
in ether-linked DHPC for a series of P/L ratios at 20C and
50C, respectively. At the lower temperature (i.e., below the
transition temperature of DHPC), the OCD spectrum of
alamethicin incorporated into the DHPC lipid bilayer, with
a P/L ratio of 1:15, demonstrates a helix oriented parallel to
the light or to the bilayer normal (I state), as described by
Huang et al. (7,42). The OCD spectrum of sample containing
P/L ratio 1:120 represents the helix oriented perpendicular to
the light or to the bilayer normal (S state). These data suggest
that the threshold peptide concentration (P/L*) for alame-
thicin/DHPC is between 1:40 and 1:30 at 20C. Above the
transition temperature for DHPC, i.e., at 50C when DHPC
is in liquid crystalline phase, the threshold P/L* ratio appears
to no longer exist, indicating that alamethicin is inserted in-
to the bilayer even at low concentrations, as is the case for
alamethicin in POPC at room temperature as evidenced from
15N NMR data (28). In Fig. 3, OCD spectra are shown of
alamethicin incorporated in the ester-linked phospholipid
DPPC at various lipid/peptide concentrations at 20C (gel
phase). It clearly indicates that for samples with P/L . 1:80,
the helix is predominantly in the I state. OCD experiments
were also performed for alamethicin incorporated into the
ester-linked DPhPC, yielding identical results to those
reported in the literature (16) (data not shown).
Figs. 1 and 2 therefore reveal that the threshold peptide
concentration, P/L*, for DHPC is higher (between 1:40 and
1:30) than for alamethicin in DPPC (;1:80) at 20C. This
difference can be attributed to the different properties of
these lipids. More speciﬁcally, recent experiments have
shown that membrane thinning is the cause for sudden
insertion of alamethicin in the lipid bilayer above the critical
P/L* (7,11–13). Previous reports clearly indicate that the
lipid composition, hydrophobic length, hydration, and ratio
between the area of the headgroup region (Ahg) and the area
of hydrocarbon chain region (Ach), inﬂuence the membrane
thinning process. In this study, the difference between the
P/L threshold concentrations (P/L*) for DHPC and DPPC
could be the result of several factors, such as the presence of
different phases, the hydrophobic length difference, and/or
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differences in Ahg/Ach. As hydration was carefully controlled
during sample preparation, we assume that this would play
a minor role in explaining the differences in P/L*.
As reported earlier, DHPC lipid bilayers are in interdigi-
tated phase at room temperature (;22C–24C), whereas
DPPC lipid bilayers are in gel phase. The hydrophobic
length of alamethicin is 22 A˚, whereas the distance between
the phosphate groups, dp-p, is 42 A˚ for DPPC bilayers and
31 A˚ for DHPC bilayers, at room temperature (43,44). Since
a dp-p of 42 A˚ for DPPC implies that the hydrophobic
thickness of the bilayer is 24 A˚, the length of alamethicin and
that of the DPPC bilayer are well matched. This has as a
consequence that alamethicin would be better able to insert
into DPPC than DHPC. Alternatively, the different areas
occupied by the lipid headgroups and carbon chains may also
play a role. Headgroup size of the phospholipids which
constitute the bilayer often has a pronounced effect on the
threshold P/L* of antimicrobial peptides, but in these OCD
experiments for DHPC and DPPC, the phosphocholine
headgroup region is similar. A comparison of the areal ratio
between the headgroup and the hydrocarbon chains, Ahg/Ach
(45), however, shows that DHPC has a higher areal ratio
compared to DPPC. Lipids with higher Ahg/Ach values are
expected to have less room to accommodate peptides in the
headgroup region without distortion, and thus would exhibit
lower threshold P/L* ratios. This explains why, for example,
alamethicin inserts to a DMPC bilayer at a lower P/L* ratio
as compared to a DOPC bilayer (7,45). The results obtained
here for alamethicin inserted into DHPC and DPPC bilayers
do not follow this rule.
Based on the OCD results, membrane thinning would
therefore occur at different P/L ratios for alamethicin in
DPPC versus DHPC, as a result of hydrophobic mismatch.
The free energy cost of such thinning, which causes
headgroup deformation, increases quadratically with the P/L.
At some critical P/L*, the energy cost of thinning exceeds
the energy for insertion, and the inserted state becomes
favored at higher P/L ratio (5,10,16,46). Studies of lipid
motility by ﬂuorescence anisotropy report a marked insta-
bility or ‘‘wobbling’’ of lipid hydrocarbon chains as the P/L
approaches P/L*, indicating that both headgroups and hy-
drocarbon tails are distorted as a result of membrane thinning
(14). Our results from 31P aligned spectra support this in-
crease in deformation of the headgroup with increasing
alamethicin concentration (vide infra).
To further characterize the insertion of alamethicin in
DHPC, solid-state 31P NMR spectroscopy (47) on MLV and
aligned samples of alamethicin/DHPC was performed. 31P
static spectra of MLV samples of DHPC were recorded as a
function of increasing alamethicin concentration and tem-
perature (data not shown). The width of the powder pattern
for pure DHPC was found to be 52 ppm, in agreement with
the width of 55 ppm for a DHPC bilayer at 21C (17). Ex-
periments performed at 50C, for which DHPC is in liquid
crystalline phase, showed a reduced powder pattern width of
42 ppm. This and the fact that the axially symmetric spectral
shape and CSA parameters agree well with previous 31P
NMR studies (17) serve to conﬁrm that the lipid bilayers
studied here are in the interdigitated-gel phase (LbI). Ad-
dition of alamethicin to DHPC (P/L ratios ¼ 1:80 and 1:15)
does not change the spectral line shape and CSA parameters
of the 31P NMR spectra in any way. This indicates that the
addition of alamethicin to DHPC does not lead to the for-
mation of new phases, a result which is further conﬁrmed by
our DSC results (vide infra).
Fig. 3 A shows a proton-decoupled 31P NMR spectra of
fully hydrated MLVs of pure DHPC bilayers at 25C. In Fig.
3 B, the 31P NMR spectra of a mechanically aligned DHPC
(pure) bilayer at 25C is illustrated. The presence of a single
intense peak at 35 ppm indicates that the DHPC bilayer
normal is aligned parallel to the external magnetic ﬁeld. Fig.
3, C–G, shows the 31P NMR spectra of mechanically aligned
DHPC bilayer with increasing alamethicin concentration:
the P/L ratio varies from 1:90, 1:80, 1:50, and 1:30 to 1:15,
respectively. The presence of an intense peak at 34 ppm
indicates that a signiﬁcant proportion of the DHPC mem-
brane bilayer remains aligned even at higher peptide con-
centration. Comparison of Fig. 3, E–G with Fig. 3 B clearly
suggests that the addition of alamethicin does, however,
partially disrupt the lipid orientation, as manifested by the
increased intensity at 17 ppm. This peak position rep-
resents a bilayer normal alignment perpendicular to the
magnetic ﬁeld. At the highest alamethicin concentration (P/L
ratio ¼ 1:15), for which alamethicin is in the I state (from
OCD data), an additional isotropic peak appears (at;0 ppm,
Fig. 3 G), which could originate from either the formation of
smaller vesicles/micelles, the formation of a different phase
(e.g., cubic phase), or from toroidal pore defects within the
bilayer (30,48).
The presence of these additional peaks (i.e., at;16 ppm
and at the isotropic peak position) with increasing peptide
concentration have also been observed in a number of other
FIGURE 2 Overlay of OCD spectra of alamethicin in the presence of
ester-linked DPPC as a function of peptide/lipid concentration, at room
temperature: P/L¼ 1:30 (squares), P/L¼ 1:40 (triangles), P/L¼ 1:80 (solid
circles), P/L ¼ 1:100 (x), and P/L ¼ 1:120 (bars).
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31P NMR spectra of mechanically aligned bilayers of
peptides incorporated into a range of lipid types. Examples
include the peptide paradaxin incorporated into the DMPC or
POPE lipid bilayers (29), myelin basic protein, inserted in
the POPC lipid bilayers (49), RTD-1 incorporated into
POPC, DMPC, DLPC bilayers (50), protegrin-1 (PG-1)
incorporated to POPC/cholesterol bilayers (30), K2(LA)xK2
incorporated into mechanically aligned DCPC, DLPC,
DOPC, and POPC bilayers (51), LL37, an amphipathic, an-
timicrobial peptide which inserts into POPC/POPG, POPC/
cholesterol, and POPE/POPG bilayers (52), and ﬁnally MSI-
78, which forms toroidal pores in POPC at concentrations of
1–5 mol % (53). In some cases, the presence of these
additional peaks and/or broadening of the peak shapes have
been attributed to a peptide-induced lipid phase transition. In
other cases, it has been attributed to a peptide-induced dis-
ordering effect of the peptide on the lipid bilayer, which may
arise due to hydrophobic mismatch between the peptide and
the lipid (51). Although, as mentioned above, the 31P spectra
obtained for MLV samples of DHPC/alamethicin suggest
that there is no formation of a new lipid phase, we also con-
ducted DSC experiments to determine whether alamethicin
induces new phase transitions in DHPC.
Fig. 4 shows a series of DSC heating thermograms of large
MLVs composed of fully hydrated DHPC, 1:80 alamethicin/
DHPC, and 1:15 alamethicin/DHPC, respectively. DHPC
typically undergoes two endothermic transitions upon heat-
ing: a pretransition at Tm ¼ 34C–35C and a large-enthalpy
main transition to liquid-crystalline phase at Tm ¼ 44C–
45C (43). This DSC study clearly reveals that the addition
of increasing amounts of alamethicin to DHPC does not
induce new phase transitions. It does, however, have a small
effect, by shifting the pretransition slightly and broadening
the main transition. This is consistent with previously
reported data for alamethicin (37). This effect is small as
compared to alamethicin in DPPC, where the thermograms
reveal a phase transition temperature which is reduced
slightly and a phase transition peak which is broadened
extensively upon addition of alamethicin (data not shown).
This is again consistent with earlier results obtained from
differential thermoanalysis of DPPC in the presence of
alamethicin (37).
The evidence described thus far, therefore, suggests that
alamethicin induces a disordering effect on DHPC, which is a
result of membrane-thinning which occurs at high alamethi-
cin concentrations. To further quantify this disordering ef-
fect, we have performed 31P inversion recovery experiments
for three samples—DHPC (100%), alamethicin/DHPC
(P/L ¼ 1:80), and alamethicin/DHPC (P/L ¼ 1:15)—to
understand the headgroup motions in MLVs. To ﬁrst ap-
proximation, the inversion recovery of the whole powder
pattern could be described by a single T1 value, therefore the
T1 relaxation values were evaluated at the 15 ppm for
MLV samples (Table 1), as described in the Materials and
FIGURE 3 31P NMR spectra of (A) pure DHPC MLVs (fully hydrated);
(B) oriented pure DHPC; and (C–F) oriented DHPC lipid bilayers with
increasing alamethicin concentration, i.e., P/L ¼ 1:90, 1:80, 1:50, 1:30, and
1:15, respectively. For all oriented samples, the glass plates are oriented such
that the bilayer normal is oriented parallel to the magnetic ﬁeld. The
temperature was set at 25C.
FIGURE 4 DSC heating thermograms for (solid line) pure DHPC,
(dashed line) P/L ¼ 1:80 alamethicin/DHPC, and, ﬁnally, (dotted line)
P/L ¼ 1:15 alamethicin/DHPC. See text for more details.
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Methods section. As a check, a T1 value was also determined
for pure POPC multilamellar vesicles (T1 ¼ 980 6 50 ms at
24C), which agrees with the value reported in the literature
(39). For DHPC, the addition of alamethicin clearly only has
a slight effect on the relaxation rate 1/T1, with the largest
effect being observed for the 1:80 alamethicin/DHPC ratio,
where T1 is reduced by ;100 ms at 24C. It is consistent
with the model that alamethicin interacts with a larger
number of DHPC headgroups when it is in a surface as-
sociated or S state, though the large experimental error does
not prove this conclusively. The decrease in T1 values with
increased temperature indicates that the headgroups undergo
more motion in the interdigitated-gel phase than in the liquid
crystalline phase at 50C.
To try to determine whether the disordering effect of
alamethicin on the DHPC bilayer is due to hydrophobic
mismatch, 31P NMR spectra were also measured for me-
chanically aligned ester-linked POPC bilayers, with the same
P/L ratios. As mentioned previously, the hydrophobic length
of alamethicin is 22 A˚, whereas the hydrocarbon distance is
13 A˚ for DHPC bilayers, 24 A˚ for DPPC bilayers (44), and
26–27 A˚ for POPC bilayers (51). Consequently, one expects
a proportionately larger/wider peak at 16 ppm in the 31P
NMR spectrum of alamethicin in aligned DHPC than in
POPC. Fig. 5 A shows the 31P NMR spectra of POPC fully
hydrated MLVs at 25C. The width of the powder pattern for
pure POPC bilayers is 45 ppm, in agreement with the
literature (17,46). The spectral line shape and width (Figs. 3
A and 5 A) indicate that the DHPC liposomes are in inter-
digitated gel phase, whereas POPC liposomes are in liquid-
crystalline phase (17,46). Our results are also in agreement
with the spectral line shape changes observed previously for
mechanically aligned DMPC membrane bilayers from gel to
intermediate and ﬁnally to liquid crystalline phase (54).
Fig. 5, B and C, illustrates the 31P NMR spectra of the
mechanically aligned POPC bilayer with two different ratios
of alamethicin to lipid: P/L ¼ 1:80 and 1:15, respectively.
The intense narrow peak at 30 ppm indicates that the bilayer
normal aligns parallel to the magnetic ﬁeld in the presence of
alamethicin. A peak is also present at 15 ppm, suggesting
that a slight disordering in the lipid headgroup region occurs.
Comparison of Figs. 3 D with 5 B and Figs. 3 F with 5 C
indicates that the orientation disorder of lipid headgroup is
less signiﬁcant in the case when alamethicin is inserted in the
POPC as compared to DHPC. Therefore, the disordering
effect of the peptaibol is less signiﬁcant in the case of POPC
as compared to DHPC, indicating that hydrophobic thick-
ness plays a critical role in the insertion mechanism of
alamethicin in the different lipids.
Based on the data reported here and comparing with
models for the insertion of alamethicin into ester-linked lipid
bilayers (10,55–59), we therefore suggest that alamethicin
inserts into DHPC bilayers, as illustrated in Fig. 6. In Fig. 6
TABLE 1 T1 relaxation values evaluated from the 31P NMR
inversion recovery experiments of DHPC with varying
amounts of alamethicin as a function of temperature
Sample type
Alamethicin/
DHPC P/L ratio
T1 at T ¼ 24C
(in ms)
T1 at T ¼ 50C
(in ms)
Multilamellar vesicles DHPC (100%) 590 6 55 473 6 45
1:80 505 6 45 475 6 55
1:15 555 6 55 510 6 55
FIGURE 5 31P NMR spectra of (A) pure POPC MLVs (fully hydrated);
(B–C) oriented POPC lipid bilayers with increasing alamethicin concentra-
tion, i.e., P/L ¼ 1:80 and 1:15, respectively. For all oriented samples, the
glass plates are oriented such that the bilayer normal is oriented parallel to
the magnetic ﬁeld. The temperature was set at 25C.
FIGURE 6 Models of alamethicin insertion, based on the data reported in
this work. Alamethicin is depicted as a cylinder. (A) Alamethicin in ether-
linked DHPC bilayer (in interdigitated-gel phase at room temperature) in the
S state, at lower P/L ratio, whereas in B it is in the I state, at higher P/L ratios.
The orientation of alamethicin is unknown at this point; therefore the peptide
is shown as either partially inserting into the bilayer (left) or inserting/tilting
into the bilayer (right) to accommodate the large hydrophobic mismatch.
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A, at low P/L ratios, alamethicin is oriented perpendicular to
the lipid bilayer normal or surface adsorbed, with small
perturbations of the lipid headgroup. With higher and higher
P/L ratios, alamethicin increasingly inserts into the lipid
bilayer, with increasing perturbation of some of the lipid
headgroups (Fig. 6 B). Given the shape of the 31P NMR
signals observed in the aligned samples (53,60) and that the
perturbation of the lipids gradually increases as more and
more alamethicin inserts into the membrane (i.e., given that
the peptide is always associated with the lipid headgroup
(10)), we propose that alamethicin inserts into DHPC using
a toroidal mechanism. Indeed the peak shapes observed at
P/L ratios in the range 1:50–1:15 are practically identical to
the simulated 31P NMR lineshapes presented in Hallock et al.
(53). Moreover, since DHPC has a headgroup area which is
larger than the alkyl chain, it can easily accommodate the
positive curvature required for the toroidal model. This
mechanism for alamethicin insertion is different from that for
POPC bilayers, which is the barrel-stave mechanism (10,55–
59). One should note that to prove our toroidal model con-
clusively, single channel conductance measurements would
be needed (55). Finally, it should be emphasized that the
arrangement of alamethicin in DHPC bilayers is at this point
undetermined. The peptide may insert partially or it could
oligomerize or tilt (61) to minimize the large hydrophobic
mismatch between alamethicin and DHPC in the interdig-
itated phase. 15N (or 13C) NMR measurements would be
needed to further determine the orientation of alamethicin in
DHPC (28).
CONCLUSIONS
In this study, we have shown that alamethicin inserts into
both ether-linked DHPC bilayers and ester-linked DPPC or
POPC bilayers. The OCD results show that at a lower P/L
ratio, alamethicin lies on the surface of the ether-linked
DHPC membrane, whereas it inserts into the bilayer at a
higher P/L ratio. The P/L* threshold is higher for alamethicin
in DHPC (between 1:40 and 1:30) than in DPPC (;1:80) at
20C. This is likely due to the relative differences in the
hydrophobic length of alamethicin, DHPC, and DPPC. The
31P NMR data show how alamethicin increasingly perturbs
the DHPC headgroup with increasing alamethicin concen-
tration, ﬁnally leading to additional peaks at 16 ppm and at
the isotropic position. This is not accompanied by a change
in phase of the lipids, as conﬁrmed by the DSC data. Given
the results, we therefore propose that alamethicin inserts into
DHPC bilayers using the toroidal model. Further studies on
the orientation of alamethicin in DHPC are currently
underway.
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